sonnet biotherapeutics stock target price

Monday, October 24, 2022 Edit

Sonnet BioTherapeutics Holdings Inc NASDAQ. Sonnet BioTherapeutics Price Targets.

Sonnet Biotherapeutics Announces 1 For 14 Reverse Stock Split

The 1 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 2200 with a high estimate of 2200 and.

. Sonnet BioTherapeutics Holdings Inc. What analysts think SONN stock price will be. Privacy Policy Disclaimer Sitemap.

In terms of how. Sonnet BioTherapeutics Stock Slumps After 30M Equity Raise. SONN IEX Real-Time Price USD.

This is based on 1 Wall Streets Analysts 12-month price targets issued in the past 3 months. 3 Insight into Sonnet BioTherapeutics. Sonnet BioTherapeutics has a Price Target of 33.

Sonnet BioTherapeutics Holdings Inc. Change in Directors or Principal Officers Regulati. Lori McNeill to the Board of Directors and.

Find the latest Sonnet BioTherapeutics Holdings Inc H3D0BE stock quote history news and other vital information to help you with your stock trading and investing. In terms of how SONNET BIOTHERAPEUTICS HOLDINGS INC fares relative to all US stocks note that its average analyst price target is higher than 7883 of that group. Analyze Sonnet BioTherapeutics target price and analyst consensus to evaluate buy or sell recommendation on Sonnet BioTherapeutics.

SONN priced the underwritten public offering of 353. Sonnet Biotherapeutics Holdings Inc. Based on short-term price targets offered by two analysts the average price target for Sonnet BioTherapeutics Holdings Inc.

According to 8 stock analysts the average 12. Analyst ratings historical stock prices earnings estimates actuals. View the latest SONN stock quote and chart on MSN Money.

3 Wall Street analysts that have issued a 1 year SONN price target the average SONN price target is 200. The highest analyst price. The average Sonnet Biotherapeutics Holdings stock price.

Sonnet BioTherapeutics Appoints Ms. Sonnet BioTherapeutics presently has a consensus price target of 2800 indicating a potential upside of 180476. 2022 Sonnet BioTherapeutics Inc.

In order to regain compliance with the Rule the Companys common stock was required to maintain a minimum closing bid price of 100 or more for at least 10 consecutive. While ratings are subjective and will change the latest Sonnet BioTherapeutics SONN rating was a maintained with a price target of 200 to 2200. April 6 2020.

The average price target for Sonnet BioTherapeutics Holdings is 2200. SONN updated stock price target summary. 4 Sonnet BioTherapeutics Insider Details.

Sonnet Biotherapeutics Inc Sonn